Form 4 for ALLR Allarity Therapeutics, Inc.
Accepted 2025-10-02 00:00:00 ET · period of report 2025-09-30 · accession 0001213900-25-095391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-02 | 2025-09-30 | ALLR | Graff Jeremy R. | See Remarks | M - OptEx | — | +39.5K | 39.5K | New | — |
| D | 2025-10-02 | 2025-09-30 | ALLR | Graff Jeremy R. | See Remarks | F - Tax | $1.58 | -14.6K | 24.9K | -37% | -$23.1K |
| D | 2025-10-02 | 2025-09-30 | ALLR | Graff Jeremy R. | See Remarks | M - OptEx | $0.00 | -39.5K | 223.4K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-30 | M | A | 39,494 | — | 39,494 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-09-30 | F | D | 14,613 | $1.58 | 24,881 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-09-30 | M | D | 39,494 | $0.00 | 223,430 | D | — · — to — | 39,494 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date. |